Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00298974 · ClinicalTrials.gov registry record · Phase 3
A Study of Pain Relief in Osteoarthritis
A Phase 3 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 3
- Development phase
- 873
- Enrollment target
NCT00298974: Completed Phase 3 study, sponsored by Abbott.
NCT00298974 is a Phase 3 study that has completed, run by Abbott. The registered enrollment target is 873 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (13% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00298974, a Phase 3 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 873 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the safety and pain-relieving ability of Vicodin CR to placebo in subjects with osteoarthritis (OA) of the hip or knee.
Primary Outcome
Arthritis Pain Intensity measured by a 100mm Visual Analog Scale (VAS)
Interventions
- DRUG Placebo
- DRUG hydrocodone / acetaminophen extended release
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 873 participants |
| Start Date | 2006-02 |
| Est. Completion | 2007-05 |
| Phase | Phase 3 |
What the finished NCT00298974 record still lists
NCT00298974 is an interventional study that assigns participants to a tested intervention. The registered 873 participants enrollment target is mid-sized for trials with a published cap, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (13% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00298974 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00298974 about?
NCT00298974 is a clinical study titled "A Study of Pain Relief in Osteoarthritis". The purpose of this study is to compare the safety and pain-relieving ability of Vicodin CR to placebo in subjects with osteoarthritis (OA) of the hip or knee.
What is the current status of trial NCT00298974?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 873 participants. The study started on 2006-02. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00298974?
The interventions under investigation include: Placebo (DRUG), hydrocodone / acetaminophen extended release (DRUG).
Who is sponsoring clinical trial NCT00298974?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00298974's enrollment target sits among peer trials
873 373rd of 2000 higher than 1,628 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04097145 · 870 participants · NA
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
- NCT07076199 · 877 participants · Phase 3
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
- NCT06822790 · 869 participants · Phase 3
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
- NCT06627647 · 878 participants · Phase 3
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia